Pramipexole Dihydrochloride

Pramipexole Dihydrochloride (API)

Pramipexole dihydrochloride is an antiparkinsonian active pharmaceutical ingredient used to manufacture oral pramipexole medicines.

Uses of Finished Medicines

• Management of Parkinson’s disease symptoms, including stiffness, tremor and movement difficulties
• Restless legs syndrome as prescribed by a physician

Product Information

• English name: Pramipexole Dihydrochloride
• Therapeutic class: Antiparkinsonian agent
• Common finished dosage form: Tablets
• Known brand names: Sifrol, Restine and Mirapex

Note: This page describes pharmaceutical raw material for industrial use. It is not medical advice; finished medicines must be used as prescribed by a physician.

Reference Chemical Identity — Monohydrate Form

The values below refer to the dihydrochloride monohydrate. Confirm the available chemical form, hydration state and assay basis against the certificate of analysis (COA) with our technical team.

Identity reference: DailyMed — Pramipexole Dihydrochloride.

Technical Specifications and Quality Documents

Contact the NEB technical team for specifications, a certificate of analysis (COA), safety data sheet (SDS), packaging and availability. Reference values do not replace approved specifications or the batch-specific certificate of analysis.